{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:44:26Z","timestamp":1782603866783,"version":"3.54.5"},"reference-count":26,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The coronavirus disease 2019 (COVID-19) has become a global pandemic, which is induced by infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with systemic lupus erythematosus (SLE) are susceptible to infections due to the chronic use of immunosuppressive drugs and the autoimmune disorders. Now we report a case of SLE infected with SARS-CoV-2, influenza A virus and <jats:italic>Mycoplasma pneumoniae<\/jats:italic> concurrently. The patient used hydroxychloroquine and prednisone chronically to control the SLE. After infection of SARS-CoV-2, she was given higher dose of prednisone than before and the same dosage of hydroxychloroquine. Besides, some empirical treatments such as antiviral, antibiotic and immunity regulating therapies were also given. The patient finally recovered from COVID-19. This case indicated that hydroxychloroquine may not be able to fully protect SLE patient form SARS-CoV-2. Intravenous immunoglobulin therapies and increased dose of corticosteroids might be adoptable for patient with both COVID-19 and SLE. Physicians should consider SARS-CoV-2 virus test when SLE patient presented with suspected infection or SLE flare under the epidemic of COVID-19.<\/jats:p>","DOI":"10.1515\/med-2020-0238","type":"journal-article","created":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T14:43:38Z","timestamp":1604414618000},"page":"1054-1060","source":"Crossref","is-referenced-by-count":9,"title":["A case of SLE with COVID-19 and multiple infections"],"prefix":"10.1515","volume":"15","author":[{"given":"Ruoqi","family":"Ning","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan , 430030 , Hubei , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silu","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan , 430030 , Hubei , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangxu","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan , 430030 , Hubei , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan , 430030 , Hubei , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan , 430030 , Hubei , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan , 430030 , Hubei , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiying","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan , 430030 , Hubei , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2020,10,14]]},"reference":[{"key":"2022052423242009450_j_med-2020-0238_ref_001_w2aab3b7d869b1b6b1ab2b2b1Aa","unstructured":"WHO. Coronavirus disease (COVID-19) Pandemic. World Health Organization; 2020 [cited 2020 June 10]. Available from: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019."},{"key":"2022052423242009450_j_med-2020-0238_ref_002_w2aab3b7d869b1b6b1ab2b2b2Aa","doi-asserted-by":"crossref","unstructured":"Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708\u201320. 10.1056\/NEJMoa2002032.","DOI":"10.1056\/NEJMoa2002032"},{"key":"2022052423242009450_j_med-2020-0238_ref_003_w2aab3b7d869b1b6b1ab2b2b3Aa","doi-asserted-by":"crossref","unstructured":"Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46:846\u20138. 10.1007\/s00134-020-05991-x.","DOI":"10.1007\/s00134-020-05991-x"},{"key":"2022052423242009450_j_med-2020-0238_ref_004_w2aab3b7d869b1b6b1ab2b2b4Aa","doi-asserted-by":"crossref","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054\u201362. 10.1016\/S0140-6736(20)30566-3.","DOI":"10.1016\/S0140-6736(20)30566-3"},{"key":"2022052423242009450_j_med-2020-0238_ref_005_w2aab3b7d869b1b6b1ab2b2b5Aa","doi-asserted-by":"crossref","unstructured":"Fei Y, Shi X, Gan F, Li X, Zhang W, Li M, et al. Death causes and pathogens analysis of systemic lupus erythematosus during the past 26 years. Clin Rheumatol. 2014;33(1):57\u201363. 10.1007\/s10067-013-2383-3.","DOI":"10.1007\/s10067-013-2383-3"},{"key":"2022052423242009450_j_med-2020-0238_ref_006_w2aab3b7d869b1b6b1ab2b2b6Aa","doi-asserted-by":"crossref","unstructured":"Mathian A, Mahevas M, Rohmer J, Roumier M, Cohen-Aubart F, Amador-Borrero B, et al. Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine. Ann Rheum Dis. 2020;79(6):837\u20139. 10.1136\/annrheumdis-2020-217566.","DOI":"10.1136\/annrheumdis-2020-218795"},{"key":"2022052423242009450_j_med-2020-0238_ref_007_w2aab3b7d869b1b6b1ab2b2b7Aa","doi-asserted-by":"crossref","unstructured":"Ding Q, Lu P, Fan Y, Xia Y, Liu M. The clinical characteristics of pneumonia patients co-infected with 2019 novel coronavirus and influenza virus in Wuhan, China. J Med Virol. 2020;92:1549\u201355. 10.1002\/jmv.25781.","DOI":"10.1002\/jmv.25781"},{"key":"2022052423242009450_j_med-2020-0238_ref_008_w2aab3b7d869b1b6b1ab2b2b8Aa","unstructured":"National Health Commission of People\u2019s Republic of China. Diagnosis and Treatment Guideline for COVID-19. 6th edn. 2020 [cited 2020 August 21]. Available from: http:\/\/www.nhc.gov.cn\/yzygj\/s7653p\/202002\/8334a8326dd94d329df351d7da8aefc2.shtml."},{"key":"2022052423242009450_j_med-2020-0238_ref_009_w2aab3b7d869b1b6b1ab2b2b9Aa","doi-asserted-by":"crossref","unstructured":"Mok CC, Ying KY. Lupus pneumonitis or severe acute respiratory syndrome? Lupus. 2004;13(7):549\u201353. 10.1191\/0961203304lu1044cr.","DOI":"10.1191\/0961203304lu1044cr"},{"key":"2022052423242009450_j_med-2020-0238_ref_010_w2aab3b7d869b1b6b1ab2b2c10Aa","doi-asserted-by":"crossref","unstructured":"Ospina FE, Echeverri A, Zambrano D, Suso JP, Martinez-Blanco J, Canas CA, et al. Distinguishing infections vs. flares in patients with systemic lupus erythematosus. Rheumatology. 2017;56(Suppl 1):i46\u2013i54. 10.1093\/rheumatology\/kew340.","DOI":"10.1093\/rheumatology\/kew340"},{"key":"2022052423242009450_j_med-2020-0238_ref_011_w2aab3b7d869b1b6b1ab2b2c11Aa","unstructured":"Wang Y, Sun S, Shen H, Jiang L, Zhang M, Xiao D, et al. Cross-reaction of SARS-CoV antigen with autoantibodies in autoimmune diseases. Cell Mol Immunol. 2004;1(4):304\u20137."},{"key":"2022052423242009450_j_med-2020-0238_ref_012_w2aab3b7d869b1b6b1ab2b2c12Aa","doi-asserted-by":"crossref","unstructured":"Liu J, Cao R, Xu M, Wang X, Zhang H, Hu H, et al. Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discov. 2020;6:16. 10.1038\/s41421-020-0156-0.","DOI":"10.1038\/s41421-020-0156-0"},{"key":"2022052423242009450_j_med-2020-0238_ref_013_w2aab3b7d869b1b6b1ab2b2c13Aa","doi-asserted-by":"crossref","unstructured":"Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P, et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020;71:732\u20139. 10.1093\/cid\/ciaa237.","DOI":"10.1093\/cid\/ciaa237"},{"key":"2022052423242009450_j_med-2020-0238_ref_014_w2aab3b7d869b1b6b1ab2b2c14Aa","doi-asserted-by":"crossref","unstructured":"Fantini J, Di Scala C, Chahinian H, Yahi N. Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection. Int J Antimicrob Agents. 2020;55:105960. 10.1016\/j.ijantimicag.2020.105960.","DOI":"10.1016\/j.ijantimicag.2020.105960"},{"key":"2022052423242009450_j_med-2020-0238_ref_015_w2aab3b7d869b1b6b1ab2b2c15Aa","doi-asserted-by":"crossref","unstructured":"Heldwein FL, Calado A. Does hydroxychloroquine prevent the transmission of covid-19? Ann Rheum Dis. 2020;79:e62. 10.1136\/annrheumdis-2020-217501.","DOI":"10.1136\/annrheumdis-2020-217501"},{"key":"2022052423242009450_j_med-2020-0238_ref_016_w2aab3b7d869b1b6b1ab2b2c16Aa","doi-asserted-by":"crossref","unstructured":"Hoffmann M, Mosbauer K, Hofmann-Winkler H, Kaul A, Kleine-Weber H, Kruger N, et al. Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2. Nature. 2020;585:588\u201390. 10.1038\/s41586-020-2575-3.","DOI":"10.1038\/s41586-020-2575-3"},{"key":"2022052423242009450_j_med-2020-0238_ref_017_w2aab3b7d869b1b6b1ab2b2c17Aa","doi-asserted-by":"crossref","unstructured":"Maisonnasse P, Guedj J, Contreras V, Behillil S, Solas C, Marlin R, et al. Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates. Nature. 2020;585:584\u20137. 10.1038\/s41586-020-2558-4.","DOI":"10.1038\/s41586-020-2558-4"},{"key":"2022052423242009450_j_med-2020-0238_ref_018_w2aab3b7d869b1b6b1ab2b2c18Aa","doi-asserted-by":"crossref","unstructured":"Horby P, Mafham M, Linsell L, Bel JL, Staplin N, Emberson JR, et al.Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial. medRevix: 20151852v1 [preprint]. 2020 [cited 2020 August 21]. Available from: https:\/\/www.medrxiv.org\/content\/10.1101\/2020.07.15.20151852v1.","DOI":"10.1101\/2020.07.15.20151852"},{"key":"2022052423242009450_j_med-2020-0238_ref_019_w2aab3b7d869b1b6b1ab2b2c19Aa","doi-asserted-by":"crossref","unstructured":"Misra DP, Agarwal V, Gasparyan AY, Zimba O Rheumatologists\u2019 perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets. Clin Rheumatol. 2020;39(7):2055\u201362. 10.1007\/s10067-020-05073-9.","DOI":"10.1007\/s10067-020-05073-9"},{"key":"2022052423242009450_j_med-2020-0238_ref_020_w2aab3b7d869b1b6b1ab2b2c20Aa","doi-asserted-by":"crossref","unstructured":"Gasparyan AY, Misra DP, Yessirkepov M, Zimba O Perspectives of immune therapy in coronavirus disease 2019. J Korean Med Sci. 2020;35(18):e176. 10.3346\/jkms.2020.35.e176.","DOI":"10.3346\/jkms.2020.35.e176"},{"key":"2022052423242009450_j_med-2020-0238_ref_021_w2aab3b7d869b1b6b1ab2b2c21Aa","doi-asserted-by":"crossref","unstructured":"Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46(6):1089\u201398. 10.1007\/s00134-020-06062-x.","DOI":"10.1007\/s00134-020-06062-x"},{"key":"2022052423242009450_j_med-2020-0238_ref_022_w2aab3b7d869b1b6b1ab2b2c22Aa","doi-asserted-by":"crossref","unstructured":"Watson RA, Johnson DM, Dharia RN, Merli GJ, Doherty JU. Anti-coagulant and anti-platelet therapy in the COVID-19 patient: a best practices quality initiative across a large health system. Hosp Pract. 1995;2020:1\u201311. 10.1080\/21548331.2020.1772639.","DOI":"10.1080\/21548331.2020.1772639"},{"key":"2022052423242009450_j_med-2020-0238_ref_023_w2aab3b7d869b1b6b1ab2b2c23Aa","doi-asserted-by":"crossref","unstructured":"Ye Q, Wang B, Mao J. The pathogenesis and treatment of the \u2018Cytokine Storm\u2019 in COVID-19. J Infect. 2020;80:607\u201313. 10.1016\/j.jinf.2020.03.037.","DOI":"10.1016\/j.jinf.2020.03.037"},{"key":"2022052423242009450_j_med-2020-0238_ref_024_w2aab3b7d869b1b6b1ab2b2c24Aa","doi-asserted-by":"crossref","unstructured":"Schrezenmeier E, Dorner T. Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. Nat Rev Rheumatol. 2020;16(3):155\u201366. 10.1038\/s41584-020-0372-x.","DOI":"10.1038\/s41584-020-0372-x"},{"key":"2022052423242009450_j_med-2020-0238_ref_025_w2aab3b7d869b1b6b1ab2b2c25Aa","doi-asserted-by":"crossref","unstructured":"Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis. 2020;71:762\u20138. 10.1093\/cid\/ciaa248.","DOI":"10.1093\/cid\/ciaa248"},{"key":"2022052423242009450_j_med-2020-0238_ref_026_w2aab3b7d869b1b6b1ab2b2c26Aa","doi-asserted-by":"crossref","unstructured":"Ling Y, Xu SB, Lin YX, Tian D, Zhu ZQ, Dai FH, et al. Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients. Chin Med J (Engl). 2020;133(9):1039\u201343. 10.1097\/CM9.0000000000000774.","DOI":"10.1097\/CM9.0000000000000774"}],"container-title":["Open Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/view\/journals\/med\/15\/1\/article-p1054.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/med-2020-0238\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/med-2020-0238\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T23:36:01Z","timestamp":1653435361000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/med-2020-0238\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,1]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,11,29]]},"published-print":{"date-parts":[[2020,11,29]]}},"alternative-id":["10.1515\/med-2020-0238"],"URL":"https:\/\/doi.org\/10.1515\/med-2020-0238","relation":{},"ISSN":["2391-5463"],"issn-type":[{"value":"2391-5463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,1]]}}}